Summary. The role of a-haemolysin (AH) in the resistance of Escherichia coli strains, isolated from patients with extra-intestinal diseases or diarrhoea, to the bactericidal activity of human serum and intracellular killing in polymorphonuclear leucocytes (PMNL) was investigated in uitro. Sets of a-haemolytic and non-haemolytic E. coli strains and sets of isogenic E. coli strains, which included wild-type a-haemolytic strains and derived strains with a reduced production of AH, were used. Compared with non-haemolytic strains, a-haemolytic strains were significantly more resistant to the bactericidal activity of 10 YO and 100 YO human serum and to intracellular killing in PMNL. Higher resistance to serum killing and to intracellular killing in PMNL was also found in wild-type a-haemolytic E. coli than in isogenic bacteria with reduced production of AH. These results provide evidence that production of AH in E. coli strains counteracts both the bactericidal activity of serum and intracellular killing in PMNL.
Introduction
From studies in recent years it appears that Escherichia coli strains isolated from cases of intestinal and extra-intestinal diseases are endowed with certain traits considered of importance for virulence. These include production of bacterial adhesins,' certain 0 group2 and K antigen^,^ expression of the siderophore aeroba~tin,~ production of colicin V,5 production of thermolabile and thermostable enterotoxins,' verocytotoxin,' cytotoxic necrotising factor,* a-haemolysin9 (AH) and resistance to the bactericidal activity of serum'' and to phagocytosis.' ' In E. coli, it has been shown that several properties of the bacterial cell-wall complex function as determinants of resistance to the bactericidal effect of serum. Rough phenotypes are, generally, more sensitive to serum killing than are smooth strains.12 Moreover, it has been shown that certain plasmids can increase the resistance of E. coli to serum killing, presumably via a mechanism that causes a modification in the bacterial surface.13 From several reports it is known that capsular antigens play an important role in virulence of bacteria, conferring serum resistance and inhibiting phagocytosi~.~~-~' Another factor influencing phagocytosis is AH. Gadeberg reported that AH may damage cells of the host immune system, i.e., human blood monocytes and polymorphonuclear leucocytes (PMNL). In our previous report^,'^*^^ we suggested that AH may contribute to the resistance of E. coli strains isolated from intestinal and extra-intestinal diseases to serum bactericidal effects and to phagocytosis. To establish if this is true, we have compared the response of groups of a-haemolytic and non-haemolytic E. coli strains, and sets of isogenic strains differing in AH production, to the bactericidal activity of human serum and intracellular killing in PMNL.
Materials and methods

Bacterial strains
A total of 80 clinical isolates of E. coli was studied43 a-haemolytic and 37 non-haemolytic strains. They were isolated from faeces of infants with diarrhoea (5 1 isolates), or from extra-intestinal samples (29 isolates). Of these latter isolates, 13 were from pharyngeal exudate of infants with pharyngitis, eight from urine of infants with urinary tract infections and eight from mothers with vaginal discharge. The strains were serotyped with eight polyvalent and 52 monovalent 0 antisera (Imuna). Non-haemolytic mutant strains were derived from a-haemolytic E. coli strains by treatment with rifampicin.20
Serum and PMNL
between these values were considered of intermediate sensi tivi ty .
Blood from one healthy donor was obtained by venepuncture and allowed to clot for 15 min at room temperature. After centrifugation (1 500 g) the serum was removed, fractionated into small volumes and stored at -70°C until needed.
PMNL for tests of intracellular killing of E. coli were obtained from fresh, unheparinised blood of healthy donors.
QuantiJication of a-haemolysin production
The test was a modification of the method of Tabouret et aL2l An overnight culture of bacteria (1 25 pl), grown in Todd-Hewitt Broth (Difco) containing 10 mM CaCl,, was inoculated into 5 ml of the same medium and incubated in a waterbath at 37°C with agitation for 4 h. Supernates were collected after centrifugation (10000 g for 10 min at 4"C), adjusted to pH 7.0-7-4 with 1 N NaOH and assayed for haemolytic activity in polystyrene microtitration plates. Two-fold dilutions (in 100-pl volumes) of culture supernate in Tris-buffered saline, pH 74, containing 0.01 M CaCl, were made; 50 p1 of washed sheep erythrocytes (1 % suspension) was added to each dilution and the mixtures were incubated at 37°C for 2 h with occasional shaking. After incubation, 0.1 ml of saline was added and unlysed erythrocytes were pelleted by centrifugation (1000 g for 2 min). Determination of 50% haemolysis was based on counting of unlysed erythrocytes in a Burker chamber. The number of haemolytic units (HUSO/ml) was expressed as the dilution corresponding to 50 % haemolysis.
Serum bactericidal assay
The assay was a slight modification of a method previously described.,, Overnight cultures of E. coli grown at 37°C on blood agar, were harvested. The cell suspensions were adjusted in Hanks's Balanced Salts Solution (HBSS) to contain 2.5 x lo4 cfu/ml. Microplates were employed for incubation of bacteria with serum. One well contained 0.05 ml of 10 YO or 100 YO serum. The control well contained 0.05 ml of HBSS instead of serum. The microplates were sealed with adhesive tape to prevent evaporation and placed on a roller (angle 45") and rotated for 180 min. Samples (10 pl) were withdrawn after incubation for 60, 120 and 180 min at 37°C and spread on blood agar plates. The plates were incubated for 18 h at 37°C and the viable count was determined. Susceptibility of bacteria to serum bactericidal activity was expressed as percentage of bacteria surviving after 180 min in relation to the original count of bacteria found at 0 min in the controls. Susceptibility of bacteria to serum was estimated by the Benge method.23 Strains were termed serum sensitive if the viable count dropped to 1 % of the initial value and resistant if > 90% of organisms survived after 180 min. Strains that gave results
Intracellular killing in PMNL
The intracellular killing of bacteria by human PMNL was determined microscopically with a slightly modified acridine orange staining method. 24 Fresh human blood (0.2 ml) was placed on a sterile cover slip in a humidified plastic chamber and allowed to clot for 60min at 37°C. Coagulated blood was removed by rinsing the cover slips gently in warm (37°C) HBSS. Bacteria pre-opsonised in 100 YO serum at 37°C for 15 min were placed on to the PMNL monolayer. After incubation for 60'min, the cover slips were removed, air dried and stained with acridine orange (1 mg/ml) for 1 min. In this assay, intracellular bacteria fluoresce green when viable and red if non-viable. The viability of organisms in a total of 100 PMNL was estimated. The percentage killed was the percentage of intracellular organisms that were non-viable (red), i.e., total number of non-viable percent bacteria in 100 PMNL --killed total number of intracellular bacteria
Statistical analyses
The x2 test was used for statistical comparison of the proportion of serum resistant isolates in a-haemolytic versus non-haemolytic E. coli, and of the relationship of 0 type with isolate origin, AH and serum resistance. Differences in intracellular killing (a-haemolytic versus non-haemolytic isolates) were estimated by Student's t test (two-samples analysis). Statistical comparison of results in wild-type strains and isogenic derivatives was made by Student's paired t test. Values of p < 0.05 were regarded as significant.
Results
Association of 0 type with isolate origin, AH and serum resistance
Of the 80 E. coli strains, 29 were from extraintestinal sources and 51 from faeces (table I); 60 strains were typable and belonged to 20 0 serogroups.
Of the 20 non-typable strains, four (1 3.8 YO) were from extra-intestinal sources and 16 (3 1.4 YO) from faeces.
Serogroup 0 6 was significantly more frequent among strains from extra-intestinal sources than among those from faeces (24.1 % versus 3.9 %, p < 0.01). A marked, but not statistically significant, difference was in the presence of serogroup 055 among isolates from faecal specimens compared to those from extra-intestinal sources (233 YO versus 13.5 %). Serogroup 026 was found with the same frequency among strains isolated Results of killing of a-haemolytic and non-haemolytic E. coli in serum and PMNL are shown in table 11. There were differences between the response of isolates to 10% and 100% serum. A greater proportion of a-haemolytic than non-haemolytic strains was serum resistant. When 10 % serum was employed all the a-haemolytic isolates were resistant to serum killing, but only 84% of non-haemolytic strains k2 = 7.54, p < 0.01). When 100 YO serum was used, 63 YO of the a-haemolytic strains were resistant compared to 22% of the non-haemolytic strains k2 = 13-69, p < 0.01).
Response of wild-type a-haemolytic E. coli and their non-haemolytic derivatives to killing by serum and PMNL
After treatment with 100 YO serum for 180 min, the survival of non-haemolytic derivatives was markedly depressed compared with wild-type a-haemolytic isolates (t = 4.62, p -c 0.01). Similarly, in wild-type ahaemolytic isolates compared to their non-haemolytic derivatives there was significantly higher resistance to intracellular killing in PMNL (t = 4438, p c 0.01). 
Discussion
In this paper serum resistance and intracellular killing of a-haemolytic and non-haemolytic E. coli strains were compared. Not much has been known about the role of AH in resistance of E. coli to the bactericidal activity of human serum and intracellular killing in PMNL. As previously described, production of AH is associated with certain 0 antigens25 and it is largely found in E. coli causing extra-intestinal infections,26 rarely in isolates from healthy people.8 In earlier reports, Knipschildt2' and Kauffman28 demonstrated that haemolytic E. coli strains belonged mainly to 0 groups 2 , 4 and 6. Hughes et al. 25 found 50% of E. coli strains of groups 018 and 0 7 5 were haemolytic. Moreover, they suggested an association of AH production and serum resistance with serogroups 0 6 , 0 1 8 and 075. Our results showed that AH production and serum resistance were associated with 0 groups 6 and 5 5 ; the former dominated in extra-intestinal isolates and the latter in faecal isolates.
Several reports have shown that there are various virulence determinants at the cell-wall surface that may play certain roles in the resistance of E. coli strains to the bactericidal activity of human serum.15* 29* 30 Our results indicate that AH could be another factor increasing the serum resistance of E. coli. This suggestion arises not only from the significantly higher serum resistance found in a-haemolytic isolates than in nonhaemolytic ones, but mainly from the significantly higher serum resistance found in wild-type a-haemolytic isolates than in isogenic derivatives with reduced production of AH. Hughes et al. 25 have suggested a possible role of AH in serum resistance.
Several recent reports have shown that treatment of phagocytes with AH reduces their ability to respond to chemotactic stimuli, to phagocytose bacteria and to kill them.31*32 Moreover, Gadeberg and L a r~e n~~ found that a-haemolytic E. coli were toxic to phagocytes and this cytotoxic effect corresponded with titres of AH production. However, experiments with pre-treated cells only incompletely indicate the significance of AH for the outcome of E. coli interaction with phagocytes. Results of this study support their findings; we found a lower level of killing of ahaemolytic E. coli strains in PMNL than of nonhaemolytic ones. However, there were considerable differences in intracellular killing among isolates examined. This could be ascribed to different levels of AH produced by particular isolates (unpublished observation). To distinguish a role of AH in intracellular killing, four sets of isogenic strains differing in AH production were used. The results obtained with these strains clearly demonstrate that a-haemolytic E. coli were killed to a lesser extent than isogenic strains with reduced production of AH. These results support those of Gadeberg et al. 34 who also found less intracellular killing of wild-type a-haemolytic E. coli than of their non-haemolytic derivatives.
Taking into account the results obtained in this study and those previously 24 we consider that AH contributes not only to the resistance of E. coli to intracellular killing, but also to resistance to the bactericidal activity of serum. The mechanism of increased serum resistance by AH production could be explained by the finding of Bhakdi et al. 35 who have suggested that serum albumin, lipoproteins and other unidentified plasma factors are involved in neutralising AH. Serum components involved in bacterial killing may be neutralised by interaction with AH thus leading to some failure of killing. Moreover, recent reports of Milford and Taylor36 and Caprioli et a1.8137 raise the question of possible effects of extracellular products of E. coli other than AH, e.g., verocytotoxin and cytotoxic necrotising factor closely associated with AH production, on phagocyte function. Further investigations are needed to elucidate this.
